BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Synerx Pharma Announces Teva Pharmaceutical Industries Limited (TEVA) Marketing Partnership


12/11/2006 10:44:48 AM

NEWTOWN, Pa.--(BUSINESS WIRE)--Synerx Pharma, LLC announced today that it has entered into a definitive agreement with Teva Pharmaceutical Industries, Ltd. (Nasdaq: TEVA - News) whereby Synerx will develop and secure FDA approval for a number of undisclosed products. Teva will market and distribute these products in the United States under license from Synerx, upon receiving final FDA approval.

Synerx Pharma currently has ten products under various stages of development. These development efforts encompass four different dosage form categories and five exclusive Active Pharmaceutical Ingredient agreements with multiple manufacturers. The Company anticipates having 5 ANDA's filed with FDA by the close of 2006.

About Synerx Pharma, LLC:

Synerx Pharma LLC is a privately held corporation located in historic Bucks County, Pennsylvania. Established in January 2004, the company focuses primarily on cost-effective generic products aimed at meeting underserved consumer needs, particularly those involving some combination of barriers to entry.

Synerx Pharma commercializes its products through the aggressive establishment of development, manufacturing, and supply partnerships bringing quality, value-added products to the marketplace. Synerx partners with high quality contract development and manufacturing organizations, leveraging their diverse capabilities in a variety of dosage forms and delivery technologies.

Synerx Pharma welcomes inquiries concerning partnership opportunities. Inquiries from companies outside the U.S. regarding the commercialization of their products and technologies in the U.S. marketplace are also encouraged.

Contact: Synerx Pharma, LLC Douglas S. Hamilton, BSChE, MBA President 215-860-4201 doughamilton@synerxpharma.com or Walter G. Jump, Pharm.D. Vice President 215-860-4202 walterjump@synerxpharma.com

www.synerxpharma.com

Source: Synerx Pharma, LLC

>>> Discuss This Story



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES